Juvenile Idiopathic Arthritis Clinical Trials

ReadTheTrial indexes 3 studies for Juvenile Idiopathic Arthritis. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Juvenile Idiopathic Arthritis.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
33%
N/A 1
33%
Phase 3 1
33%

Trial Status Breakdown

Trials for Juvenile Idiopathic Arthritis

An Open-label, Multicenter Study of the Pharmacokinetics, Efficacy and Safety of Olokizumab in Pediatric and Adolescent Patients With Active Juvenile Idiopathic Arthritis

NCT07517575 · RECRUITING · Phase 2

Study of the Determinants of Pediatric Onset Inflammatory Diseases: Host-microbiota-environment Interactions

NCT05176795 · TERMINATED · N/A

Treatment Tapering in Oligoarticular or Rheumatoid Factor Negative Polyarticular Juvenile Idiopathic Arthritis With Inactive Disease on Biologic Therapy

NCT02840175 · COMPLETED · Phase 3

Frequently Asked Questions

What clinical trials are available for Juvenile Idiopathic Arthritis?

There are 3 clinical trials listed for Juvenile Idiopathic Arthritis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Juvenile Idiopathic Arthritis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Juvenile Idiopathic Arthritis trials in?

Current Juvenile Idiopathic Arthritis trials are distributed across: Phase 2 (1), N/A (1), Phase 3 (1).

Find More Trials